Charlie's Holdings appoints PMTA expert Dr. Edward Carmines to board; grants restricted stock to officers

Charlie's Holdings, Inc.

Appointed Dr. Edward Carmines, Ph.D., to Board effective March 2, 2022; he is a PMTA/MRTP expert who secured FDA marketing order for 22nd Century Group.
Carmines receives $60,000 annual cash retainer and 400,000 restricted shares vesting over two years.
Granted 500,000 restricted shares to President Henry Sicignano, 565,000 to CFO Matthew Montesano, and 465,000 to CIO Adam Mirkovich, vesting over three years.
Carmines will guide Charlie's PMTAs currently in 'substantive review' at the FDA; company believes submissions are distinguished and suitable for approval.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Edward Carmines

Board of Directors

CHUC · Charlie's Holdings, Inc.

Effective: 2022-03-02
Filed: March 3, 2022, 6:59 PM ET

On March 2, 2022, Charlies Holdings, Inc. (the “ Company ”) appointed Edward Carmines, Ph.D., to the Company's Board of Directors

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Edward Carmines was appointed as Board of Directors at Charlie's Holdings, Inc..

Action: appointed
Role: Board of Directors

Exact text from the filing

On March 2, 2022, Charlies Holdings, Inc. (the “ Company ”) appointed Edward Carmines, Ph.D., to the Company's Board of Directors

View on SEC.gov

Charlie's Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001851734-22-000130

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.